Introduce
Kossel Medtech (Suzhou) Co., Ltd. established in 2013, has developed into a leading vascular intervention enterprise with comprehensive production and R&D capabilities. Manufacturing and R&D products include medical devices of the intervention category of coronary, peripheral vessel, electrophysiology.
The total facility is more than 5,000 square meters. We have around 200 employees and 44% of them with bachelor degrees.
We have advanced equipment, well organized management, refined production technology, professional R&D and QC team.
Kossel was certified as National High-tech Enterprise in 2016, and passed ISO9001, ISO13485 quality management system and GMP certification.
Our Mission: Develop superb Medical Device for people's health and benefits.
Our Vision: Innovation for systematic clinical solutions, and a world-wide intervention leader.
Our Values: Be Pragmatic, Efficient, Collaborative, Willing to share,Hard Working and Dedication.
Technical Specifications:
L605 Cobalt-Chromium Alloy
Profile 0.88-1.1mm
Redial recoil <3%
Axial foreshortening<5%
Strut thickness 0.0025"
Metal coverage rate 12.6 %( 3.0mm series)
- Use Cobalt-chromium alloy as the stent material, thinner wall-thickness but stronger supporting force.
- Use Biodegradable PLGA as drug carrier & release controller
- The Sirolimus dosage is 8.5±2.1ug/mm
Size Matrix
L/mm D/mm |
8 |
12 |
13 |
15 |
16 |
18 |
20 |
21 |
23 |
24 |
28 |
29 |
33 |
38 |
40 |
2.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
- |
- |
- |
- |
- |
2.25 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
- |
- |
- |
- |
- |
2.5 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
2.75 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
3.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
3.5 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
4.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
4.5 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
5.0 |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
√ |
Production Line
FAQ